Last reviewed · How we verify
NCT07030777
The Experience of Giving Birth With Remifentanil for Pain Relief: A Qualitative Study of Mothers and Midwives
trial in Pain Management in Pregnant Women in 40 participants. Completed in 30 June 2025.
30 June 2025
Quick facts
| Lead sponsor | Nordsjaellands Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 March 2025 |
| Primary completion | 30 June 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 3 locations across Denmark |
Conditions studied
- Pain Management in Pregnant Women — all drugs for Pain Management in Pregnant Women →
- Remifentanil — all drugs for Remifentanil →
- Midwife — all drugs for Midwife →
- Qualitative Research — all drugs for Qualitative Research →
Sponsor
Nordsjaellands Hospital
Who can join
18 and older, female only, with Pain Management in Pregnant Women or Remifentanil. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Remifentanil is an ultra-short-acting opioid used for labor pain relief in several countries, offering stronger analgesia than nitrous oxide but less than epidural anesthesia. While internationally established, remifentanil has not yet been implemented in Denmark. Objective: This study aims to explore and deepen our understanding of the childbirth experience with remifentanil for pain relief, from both the birthing woman's and the midwife's perspectives. Methods: A qualitative study based on interviews with women who gave birth using remifentanil and the midwives involved in their care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07030777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Nordsjaellands Hospital trials
Trials by the same sponsor.
- NCT07167498 — Continuous Remote Vital Sign Monitoring During Labour Analgesia With Remifentanil · not yet recruiting
- NCT07237984 — Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway · not yet recruiting
- NCT06689280 — Physical Rehabilitation of Older Persons Following a Community-Acquired Infection Hospitalization - A Randomised-Control · NA · not yet recruiting
- NCT06564857 — Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation · Phase 4 · recruiting
- NCT07132723 — Associations Between Time to Reduction and Complications in Patients With Dislocated Total Hip Arthroplasty · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07030777 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nordsjaellands Hospital
- Last refreshed: 7 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07030777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing